Artículos por temáticas

Is Aquatic Therapy Optimally Prescribed for Parkinson's Disease? A Systematic Review and Meta-Analysis

Carroll LM, Morris ME, O'Connor WT, Clifford AM.

J Parkinsons Dis. 2020;10(1):59-76. doi: 10.3233/JPD-191784.

Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study

Hansen AK, Parbo P, Ismail R, Østergaard K, Brooks DJ, Borghammer P.

J Parkinsons Dis. 2020;10(1):161-171. doi: 10.3233/JPD-191774.

Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort

Graham OEE, Pitcher TL, Liau Y, Miller AL, Dalrymple-Alford JC, Anderson TJ, Kennedy MA.

Parkinsonism Relat Disord. 2020 Jan;70:36-41. doi: 10.1016/j.parkreldis.2019.11.022. Epub 2019 Nov 29.

New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson's disease

Keir LHM, Breen DP.

J Neurol. 2020 Jan;267(1):288-294. doi: 10.1007/s00415-019-09651-z. Epub 2019 Dec 5.

Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations

Chen M, Maimaitili M, Buchholdt SH, Jensen UB, Febbraro F, Denham M.

Stem Cell Res. 2020 Jan;42:101657. doi: 10.1016/j.scr.2019.101657. Epub 2019 Nov 13.

Subjective memory decline in Parkinson's disease patients with and without fatigue

Siciliano M, Trojano L, De Micco R, Russo A, Tedeschi G, Tessitore A.

Parkinsonism Relat Disord. 2020 Jan;70:15-19. doi: 10.1016/j.parkreldis.2019.11.017. Epub 2019 Nov 21.

The efficacy of the Strength, Hope and Resourcefulness Program for people with Parkinson's disease (SHARP-PWP): A mixed methods study

Murdoch KC, Larsen D, Edey W, Arsenault C, Howell A, Joyce A, Sandham T, Miyasaki JM.

Parkinsonism Relat Disord. 2020 Jan;70:7-12. doi: 10.1016/j.parkreldis.2019.11.010. Epub 2019 Nov 16.

Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications

Angelopoulou E, Pyrgelis ES, Piperi C.

Neurochem Int. 2020 Jan;132:104612. doi: 10.1016/j.neuint.2019.104612. Epub 2019 Nov 27.

Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease

Morales-Briceño H, Fung VSC.

Mov Disord. 2020 Jan;35(1):81. doi: 10.1002/mds.27934. Epub 2019 Nov 29.

Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson's disease

Oliveira LOD, da Silva PIC, Filho RPR, Progênio RCS, de Oliveira VDPS, Silva RC, de Andrade MC, da Silva Freitas JJ, Kietzer KS.

Metab Brain Dis. 2020 Jan;35(1):175-181. doi: 10.1007/s11011-019-00507-z. Epub 2019 Nov 28.

Dissecting beta-state changes during timed movement preparation in Parkinson's disease

Heideman SG, Quinn AJ, Woolrich MW, van Ede F, Nobre AC.

Prog Neurobiol. 2020 Jan;184:101731. doi: 10.1016/j.pneurobio.2019.101731. Epub 2019 Nov 25.

Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease

Parkhe A, Parekh P, Nalla LV, Sharma N, Sharma M, Gadepalli A, Kate A, Khairnar A.

Neurosci Lett. 2020 Jan 18;716:134652. doi: 10.1016/j.neulet.2019.134652. Epub 2019 Nov 25.

Altered Granger causality connectivity within motor-related regions of patients with Parkinson's disease: a resting-state fMRI study

Hao L, Sheng Z, Ruijun W, Kun HZ, Peng Z, Yu H.

Neuroradiology. 2020 Jan;62(1):63-69. doi: 10.1007/s00234-019-02311-z. Epub 2019 Nov 26.

Is Parkinson's Disease a Very Rare Pathology in Centenarians? A Clinical Study in a Cohort of Subjects

Marcon G, Manganotti P, Tettamanti M.

J Alzheimers Dis. 2020;73(1):73-76. doi: 10.3233/JAD-190717.

Postural impairments in Parkinson's disease are not associated with changes in circadian rhythms changes

Zulai LC, Albuquerque AM, Papcke C, Louzada FM, Scheeren EM.

Chronobiol Int. 2020 Jan;37(1):135-141. doi: 10.1080/07420528.2019.1692350. Epub 2019 Nov 25.